PTCT: Sephience’s global PKU launch drives strong adoption, with robust pipeline and disciplined growth
Menos de 1 minuto de leitura
Sephience’s global PKU launch shows rapid adoption and strong patient enthusiasm, driven by its unique clinical profile and support infrastructure. The company is expanding manufacturing, managing pricing, advancing R&D, and maintaining expense discipline. Regulatory engagement and partnerships support growth and future launches.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr